Aliases & Classifications for Blepharitis

MalaCards integrated aliases for Blepharitis:

Name: Blepharitis 12 76 37 29 55 44 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:9423
MeSH 44 D001762
NCIt 50 C112183
SNOMED-CT 68 41446000
KEGG 37 H01644

Summaries for Blepharitis

Disease Ontology : 12 An eyelid disease that is characterized by often chronic inflammation of the eyelid, generally the part where eyelashes grow.

MalaCards based summary : Blepharitis is related to blepharoconjunctivitis and keratosis follicularis spinulosa decalvans, x-linked, and has symptoms including erythema of the eyelids An important gene associated with Blepharitis is MMP9 (Matrix Metallopeptidase 9), and among its related pathways/superpathways are Protein processing in endoplasmic reticulum and Microglia Activation During Neuroinflammation: Microglia Polarization. The drugs Acitretin and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and skin.

Wikipedia : 76 Blepharitis (/bl�?f�?�?raɪtɪs/ BLEF-�?r-EYE-tis) is one of the most common ocular conditions... more...

Related Diseases for Blepharitis

Diseases related to Blepharitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 61)
# Related Disease Score Top Affiliating Genes
1 blepharoconjunctivitis 32.0 CCL11 NIPAL4 SHE
2 keratosis follicularis spinulosa decalvans, x-linked 32.0 MBTPS2 SAT1
3 ulcerative blepharitis 12.3
4 squamous blepharitis 12.2
5 meibomian cyst 11.4
6 focal facial dermal dysplasia 3, setleis type 11.2
7 ichthyosis, congenital, autosomal recessive 11 11.0
8 hordeolum externum 11.0
9 eyelid disease 11.0
10 conjunctivitis 10.4
11 herpes simplex 10.3
12 lupus erythematosus 10.2
13 rosacea 10.2
14 discoid lupus erythematosus 10.2
15 keratosis follicularis spinulosa decalvans 10.2 MBTPS2 SAT1
16 keratosis 10.2 MBTPS2 SAT1
17 corneal degeneration 10.1 MBTPS2 SAT1
18 chronic meningitis 10.1 CCL11 MMP9
19 dermatitis 10.1
20 angiostrongyliasis 10.1 CCL11 MMP9
21 eosinophilic meningitis 10.0 CCL11 MMP9
22 vernal keratoconjunctivitis 10.0 CCL11 MMP9
23 strongyloidiasis 10.0 CCL11 SHE
24 folliculitis 10.0 CCL11 SAT1
25 crohn's colitis 10.0
26 phlyctenulosis 10.0
27 ectropion 10.0
28 hair disease 10.0 MBTPS2 SAT1
29 autoimmune disease 9.8
30 systemic lupus erythematosus 9.8
31 melkersson-rosenthal syndrome 9.8
32 rheumatoid arthritis 9.8
33 trichomegaly 9.8
34 dermatitis, atopic 9.8
35 basal cell carcinoma 1 9.8
36 anxiety 9.8
37 riboflavin deficiency 9.8
38 alopecia 9.8
39 arthritis 9.8
40 cataract 9.8
41 crohn's disease 9.8
42 cutaneous leishmaniasis 9.8
43 keratoconus 9.8
44 neutropenia 9.8
45 colitis 9.8
46 dry eye syndrome 9.8
47 pasteurellosis 9.8
48 uveitis 9.8
49 giant papillary conjunctivitis 9.8
50 papillary conjunctivitis 9.8

Comorbidity relations with Blepharitis via Phenotypic Disease Network (PDN):


Acute Cystitis Conjunctivitis
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Hypertension, Essential
Parkinson Disease, Late-Onset Schizophreniform Disorder

Graphical network of the top 20 diseases related to Blepharitis:



Diseases related to Blepharitis

Symptoms & Phenotypes for Blepharitis

UMLS symptoms related to Blepharitis:


erythema of the eyelids

Drugs & Therapeutics for Blepharitis

Drugs for Blepharitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 121)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acitretin Approved Phase 4 55079-83-9 5284513 6437841
2
Hyaluronic acid Approved, Vet_approved Phase 4,Not Applicable 9004-61-9 53477741
3
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
4
Azithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 83905-01-5 55185 447043
5
Tobramycin Approved, Investigational Phase 4,Phase 3,Not Applicable 32986-56-4 36294 5496
6
Loteprednol Approved, Experimental Phase 4,Phase 3,Phase 2,Not Applicable 82034-46-6, 129260-79-3 9865442 444025
7
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 564-25-0 54671203
8
Minocycline Approved, Investigational Phase 4,Not Applicable 10118-90-8 5281021
9
Glycerol Approved, Investigational Phase 4 56-81-5 753
10
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
11
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 1177-87-3
12
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
13
Dipivefrin Approved Phase 4,Phase 3 52365-63-6 3105
14
Chloramphenicol Approved, Vet_approved Phase 4 56-75-7 5959 298
15
Fusidic Acid Approved, Investigational Phase 4 6990-06-3 3000226
16
Permethrin Approved, Investigational Phase 4 52645-53-1 40326
17
Formaldehyde Approved, Vet_approved Phase 4 50-00-0 712
18
Chloramphenicol succinate Experimental Phase 4 3544-94-3
19 Dermatologic Agents Phase 4,Not Applicable
20 Keratolytic Agents Phase 4
21 Ophthalmic Solutions Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
22 Pharmaceutical Solutions Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
23 Adjuvants, Immunologic Phase 4,Not Applicable
24 Immunologic Factors Phase 4,Phase 2,Phase 1,Not Applicable
25 Viscosupplements Phase 4,Not Applicable
26 Protective Agents Phase 4,Not Applicable
27 Erythromycin stearate Phase 4
28 Erythromycin Estolate Phase 4
29 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
30 Gastrointestinal Agents Phase 4,Phase 3,Phase 2
31 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable
32 Erythromycin Ethylsuccinate Phase 4
33 Lubricant Eye Drops Phase 4,Phase 1,Phase 2
34 Anti-Allergic Agents Phase 4,Phase 3,Phase 2,Not Applicable
35 Antibiotics, Antitubercular Phase 4,Phase 3,Not Applicable
36 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Not Applicable
37 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Not Applicable
38 Antimalarials Phase 4,Phase 2,Not Applicable
39 Laxatives Phase 4,Phase 3
40 Carboxymethylcellulose Sodium Phase 4,Phase 3
41 Cathartics Phase 4,Phase 3
42 Analgesics Phase 4
43 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Not Applicable
44 Analgesics, Non-Narcotic Phase 4
45 Anti-Inflammatory Agents, Non-Steroidal Phase 4
46 Antirheumatic Agents Phase 4,Phase 1,Phase 2,Not Applicable
47 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
48 BB 1101 Phase 4,Phase 3,Phase 2
49 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2
50 Hormones Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 69)
# Name Status NCT ID Phase Drugs
1 Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects? Unknown status NCT01228409 Phase 4 Acitretin 17.5 mg/day
2 Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Completed NCT01478256 Phase 4 Erythromycin;Besifloxocin
3 Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis Completed NCT01357538 Phase 4 Posiformin 2 %, bibrocathol;Placebo Comparator
4 Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis Completed NCT00629941 Phase 4 AzaSite®
5 Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis Completed NCT00656539 Phase 4 AzaSite®
6 Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis Completed NCT00629980 Phase 4 AzaSite®
7 Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis Completed NCT00629590 Phase 4 AzaSite®
8 Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis Completed NCT01456780 Phase 4 Loteprednol/tobramycin;Loteprednol;B+L Advanced Eye Relief Lubricant Drop
9 Lipids of the Human Tear Film and Their Effect on Tear Stability Completed NCT00803452 Phase 4 doxycycline;azithromycin
10 Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye Completed NCT00987727 Phase 4 carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD);sodium hyaluronate 0.18% (VISMED® Multi)
11 Topical Nepafenac as Supplement for Diabetic Macular Edema Completed NCT02443012 Phase 4 Topical Gutt Nepafenac 0.1%
12 Zylet vs TobraDex in Blepharokeratoconjunctivitis Completed NCT00447577 Phase 4 Loteprednol etabonate and tobramycin ophthalmic suspension;Tobramycin and dexamethasone ophthalmic suspension
13 The Efficacy of Permethrin 5%, Fusidic Acid 1% and Synthomycine 5% for Demodex - Blepharitis Enrolling by invitation NCT03105505 Phase 4 Permethrin 5%;Synthomycine 5%;Fusidic Acid 1% M/R Eye Drops
14 A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis Completed NCT01102244 Phase 3 Tobradex ST;Azasite
15 Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Completed NCT02236403 Phase 3 Ivermectin 0.1% Metronidazole 1%
16 Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Completed NCT01408082 Phase 3 ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined);Azasite;Dexamethasone
17 Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis Completed NCT00732446 Phase 3 Moxifloxacin and Dexamethasone combined;Moxifloxacin;Dexamethasone
18 Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes Completed NCT00796926 Phase 3 Systane Ultra eyedrops;Refresh eye drops
19 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis Completed NCT01028027 Phase 3 Loteprednol and tobramycin;Tobramycin and dexamethasone
20 Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops Completed NCT01087671 Phase 3 tafluprost
21 Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects Recruiting NCT01543490 Phase 3 ISV-305
22 Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Withdrawn NCT01721694 Phase 3 azithromycin 1.5%/Loteprednol 0,5% + placebo;azithromycin 1.5% + Loteprednol 0,5% (separately)
23 Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. Unknown status NCT02300818 Phase 1, Phase 2 Seawater eyedrops
24 Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 Unknown status NCT02656394 Phase 2 GL101;Placebo
25 Oral Azithromycin Versus Doxycycline in Posterior Blepharitis Completed NCT01783860 Phase 2 Azithromycin;Doxycycline
26 Tea Tree Oil in the Treatment of Chronic Blepharitis Completed NCT01073150 Phase 2 Tea Tree Oil
27 Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis Completed NCT01089608 Phase 2 Azithromycin;Povidone
28 Topical IL-1-Ra for Treatment of Posterior Blepharitis Completed NCT00681109 Phase 1, Phase 2 2.5% IL-1Ra;Placebo;5% IL-1Ra
29 Treatment of Patients With Blepharitis and Facial Rosacea Completed NCT00560703 Phase 2 COL-101 (doxycycline, USP) capsules;placebo
30 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period Completed NCT00892970 Phase 2 Azithromycin ophthalmic solution, 1%;Placebo
31 The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) Completed NCT00894530 Phase 2 Azithromycin ophthalmic solution, 1%;Placebo
32 Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Completed NCT02218489 Phase 2 KPI-121;Vehicle
33 Evaluation and Treatment of Eye Complications of Vaccinia Vaccination Completed NCT00081835 Phase 2 NP-016 Vaccine Immune Globulin (IV-VIG)
34 Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma Active, not recruiting NCT01740297 Phase 1, Phase 2 Talimogene laherparepvec;Ipilimumab
35 A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) Terminated NCT01269658 Phase 2 Azithromycin ophthalmic solution, 1%;Vehicle
36 A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641) Terminated NCT01220258 Phase 2 Azithromycin ophthalmic solution, 1%
37 A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates Terminated NCT00579020 Phase 2 Moxifloxacin/dexamethasone phosphate ophthalmic solution;Moxifloxacin ophthalmic solution 0.5%;Dexamethasone phosphate solution, 0.1%
38 Study to Determine the Effect of Azasite on Corneal Surface Irregularity Withdrawn NCT01797107 Phase 2 Azasite
39 Demodex Blepharitis Treatment Study Completed NCT01647217 Phase 1 Terpinen-4-ol
40 Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora Unknown status NCT02455895 Not Applicable
41 Ocular Comfort and Inflammation in Lid Hygiene Therapy Unknown status NCT02938078 Not Applicable
42 Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma Unknown status NCT01284439 Not Applicable hydroxypropylmethylcellulose;sodium hyaluronate
43 Study to Evaluate the Safety and Efficacy of HI-BRITE Large Diameter Rigid Gas Permeable Contact Lens Unknown status NCT02812316 Not Applicable
44 Blephacura Versus Baby Shampoo to Treat Blepharitis Completed NCT01115192 Not Applicable
45 To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis Completed NCT03301844 Not Applicable
46 Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis Completed NCT02952079 Not Applicable
47 Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery Completed NCT01808560 Not Applicable
48 Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points Completed NCT00345241 Not Applicable Systane Ocular Drops (OTC);Placebo - Saline Drops
49 A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome Completed NCT00344721 Not Applicable
50 Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia Completed NCT01308333

Search NIH Clinical Center for Blepharitis

Cochrane evidence based reviews: blepharitis

Genetic Tests for Blepharitis

Genetic tests related to Blepharitis:

# Genetic test Affiliating Genes
1 Blepharitis 29

Anatomical Context for Blepharitis

MalaCards organs/tissues related to Blepharitis:

41
Eye, Testes, Skin

Publications for Blepharitis

Articles related to Blepharitis:

(show top 50) (show all 301)
# Title Authors Year
1
Better detection of <i>Demodex</i> mites by LAPffler's alkaline methylene blue staining in patients with blepharitis. ( 29713140 )
2018
2
Satisfaction and convenience of using terpenoid-impregnated eyelid wipes and teaching method in people without blepharitis. ( 29379270 )
2018
3
The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis. ( 29074306 )
2018
4
Eyelid tinea with blepharitis due to Microsporum canis. ( 29859733 )
2018
5
Comparison of the Clinical Efficacy of Topical and Systemic Azithromycin Treatment for Posterior Blepharitis. ( 29493395 )
2018
6
Development and evaluation of a measure of patient-reported symptoms of Blepharitis. ( 29325546 )
2018
7
Randomized double-masked trial of eyelid cleansing treatments for blepharitis. ( 29128682 )
2018
8
The use of tea tree oil in treating blepharitis and meibomian gland dysfunction. ( 29563688 )
2018
9
The impact of age, sex, blepharitis, rosacea and rheumatoid arthritis on <i>Demodex</i> mite infection. ( 29593809 )
2018
10
Blepharitis caused by deep trichophytosis - tinea ciliaris. ( 29927550 )
2018
11
Chronic blepharitis. ( 29947143 )
2018
12
Tiefe Trichophytie unter dem Bild einer Blepharitis - Tinea ciliaris. ( 29989360 )
2018
13
Evaluation of the Efficacy of Tea Tree Oil On the Density of Demodex Mites (Acari: Demodicidae) and Ocular Symptoms In Patients With Demodectic Blepharitis. ( 30016200 )
2018
14
Relationship between blepharitis and components of the metabolic syndrome. ( 30031612 )
2018
15
Investigation of Demodex Parasite Existence in Treatment-Resistant Chronic Blepharitis Cases. ( 30070644 )
2018
16
Quantitative Analysis of the Bacteria in Blepharitis With Demodex Infestation. ( 30108572 )
2018
17
Safety and efficacy of 4-terpineol against microorganisms associated with blepharitis and common ocular diseases. ( 30123842 )
2018
18
Prevalence and Load of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in Patients With Chronic Blepharitis in the Province of Erzincan, Turkey. ( 30137440 )
2018
19
Demodex blepharitis: clinical perspectives. ( 30214343 )
2018
20
Phthiriasis palpebrarum presenting as anterior blepharitis. ( 30232978 )
2018
21
Occurrence of Demodex species in patients with blepharitis and in healthy individuals: a 10-year observational study. ( 30255395 )
2018
22
Blepharitis Preferred Practice Pattern®. ( 30366800 )
2018
23
Association of Blepharitis and Ectropion With Tumor Necrosis Factor α Inhibitor Treatment in Crohn Disease. ( 30419086 )
2018
24
Severe chronic blepharitis. Torpid evolution of several years. ( 30447950 )
2018
25
Healthcare delivery in meibomian gland dysfunction and blepharitis. ( 30458245 )
2018
26
Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study. ( 29146760 )
2017
27
High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff. ( 28552438 )
2017
28
Blepharitis ( 29083763 )
2017
29
Chronic blepharitis like picture in patients with Discoid lupus erythematosis - Case series. ( 29634708 )
2017
30
Meibography for eyes with posterior blepharitis. ( 28860908 )
2017
31
Retraction of: Azithromycin 1.5% Ophthalmic Solution for Blepharitis Treatment: Comparison of 14- Versus 30-Day Treatment; DOI: 10.1089/jop.2015.0099. ( 28605219 )
2017
32
Preclinical development of MGO Manuka Honey microemulsion for blepharitis management. ( 29354709 )
2017
33
Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis. ( 29354710 )
2017
34
Tacrolimus Ointment for Refractory Posterior Blepharitis. ( 28922018 )
2017
35
The association of keratoconus with blepharitis. ( 29232760 )
2017
36
Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: a nationwide population-based cohort study. ( 28183148 )
2017
37
Unilateral Blepharitis With Fine Follicular Scaling. ( 28920471 )
2017
38
Demodex Blepharitis Treated with a Novel Dilute Povidone-Iodine and DMSO System: A Case Report. ( 28643231 )
2017
39
Acute blepharitis: an unusual complication of zoledronic acid. ( 26412501 )
2017
40
Blepharitis With Facial Numbness and Ocular Pain. ( 28880989 )
2017
41
Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis. ( 26788833 )
2016
42
Recurrent Fungal Keratitis and Blepharitis Caused by Aspergillus flavus. ( 27621301 )
2016
43
Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis. ( 27349766 )
2016
44
DEBS - a unification theory for dry eye and blepharitis. ( 28003734 )
2016
45
A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis. ( 27570444 )
2016
46
Oral azithromycin and blepharitis: symptoms and signs improve, so where are the publications? ( 27356302 )
2016
47
Meibomian gland dysfunction: azithromycin and objective improvement in outcomes in posterior blepharitis. ( 27314917 )
2016
48
The Effect of Demodex Infestation on Blepharitis and the Ocular Symptoms. ( 26783981 )
2016
49
Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis. ( 27500111 )
2016
50
Phthiriasis palpebrarum masquerading as seborrheic blepharitis. ( 29896824 )
2016

Variations for Blepharitis

Expression for Blepharitis

Search GEO for disease gene expression data for Blepharitis.

Pathways for Blepharitis

Pathways related to Blepharitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.02 CRYAA MBTPS2 NGLY1
2 11.01 CCL11 MMP9
3 10.76 CCL11 MMP9

GO Terms for Blepharitis

Biological processes related to Blepharitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to endoplasmic reticulum stress GO:0034976 8.96 MBTPS2 PLA2G6
2 positive regulation of release of cytochrome c from mitochondria GO:0090200 8.62 MMP9 PLA2G6

Molecular functions related to Blepharitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 collagen binding GO:0005518 8.62 LACRT MMP9

Sources for Blepharitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....